|
A Phase II Clinical Trial of ENMD-2076 in Metastatic Triple-Negative Breast Cancer: Translating a P53-Based Biomarker from Bench to Bedside |
|
|
|
Title: |
A Phase II Clinical Trial of ENMD-2076 in Metastatic Triple-Negative Breast Cancer: Translating a P53-Based Biomarker from Bench to Bedside |
Author: |
Diamond, J.R. Tan, A.C. Pitts, T.M. van Bokhoven, A. Aisner, D. Elias, A.D. Borges, V.F. Miller, K.D. Eckhardt, S.G. Tentler, J.J. |
Appeared in: |
Annals of oncology |
Paging: |
Volume 24 () nr. S1 pages i36 |
Year: |
2013 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|